NuCana plc (NCNA) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
NCNA currently has 20.8B outstanding shares. with minimal authorized share overhang for future dilution. The company has significantly diluted shareholders by 4120.33% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Mar 19, 2026 |
20-F filing | 20809.9M shares outstanding |
21B | 0 |
| Apr 24, 2025 |
F-1 filing: NuCana PLC is offering up to 16,049,383 ADSs, Pre-Funded Warrants, Series A Warrants and Series B Warrants and intends to use the net proceeds of this offering, together with our existing cash and cash equivalents, to fund activities relating to the advancement of our drug discovery and development programs, and for other general corporate purposes. |
550M | 0 |
| Mar 20, 2025 |
20-F filing | 142.0M shares outstanding |
140M | 5.8M |
| Aug 15, 2024 |
F-3 filing: The filing relates to a shelf registration for the potential issuance of up to $150,000,000 of any combination of American Depositary Shares representing Ordinary Shares, Debt Securities, Warrants, Rights, or Units. |
53M | 95M |
| Mar 20, 2024 |
20-F filing | 52.9M shares outstanding |
53M | 47M |
| Apr 04, 2023 |
20-F filing | 52.4M shares outstanding |
52M | 48M |
| Apr 27, 2022 |
20-F filing | 52.2M shares outstanding |
52M | 48M |
| Aug 19, 2021 |
F-3 filing: The filing is an F-3 type and describes a shelf offering that will allow the company to issue up to $400,000,000 of any combination of securities, including American Depositary Shares (ADSs) and debt securities. An 'at the market offering' of ADSs may be made from time to time through Jefferies LLC, with an aggregate offering price of up to $100.0 million. The company intends to use the net proceeds to fund drug discovery and development programs, and for other general corporate purposes. |
52M | 48M |
| Mar 04, 2021 |
20-F filing | 51.2M shares outstanding |
51M | 0 |
| Mar 10, 2020 |
20-F filing | 32.5M shares outstanding |
32M | 0 |